Company Overview

Company name: Joint Venture (Tetra Bio-Pharma and Altus Formulation)
Description: Developer of a series of cannabinoid-receptor targeted therapeutics addressing multiple areas of high unmet need.
Year founded:
Parent company:
Industry: Healthcare | Group: | Code:
Website:
Employees:
City: Longueuil
State: Quebec
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status:
Ownership: Privately Held (no backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF) and Altus Formulation Inc. have entered into an agreement to form a joint venture as of April 29, 2019. The joint venture will work to develop a series of cannabinoid-receptor targeted therapeutics addressing multiple areas of high unmet need.
Number of active investors:
Profile last updated: 03-May-2019
Last known valuation:
Last known valuation date: